| Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study WG Ondo, T Perkins, T Swick, KL Hull, JE Jimenez, TS Garris, D Pardi Archives of neurology 65 (10), 1337-1340, 2008 | 166 | 2008 |
| γ-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness D Pardi, J Black CNS drugs 20, 993-1018, 2006 | 148 | 2006 |
| Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): differences in characteristics and misuse LP Carter, D Pardi, J Gorsline, RR Griffiths Drug and alcohol dependence 104 (1-2), 1-10, 2009 | 133 | 2009 |
| The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy J Black, D Pardi, CS Hornfeldt, N Inhaber Journal of Clinical Sleep Medicine 6 (6), 596-602, 2010 | 97 | 2010 |
| The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy J Black, D Pardi, CS Hornfeldt, N Inhaber Sleep medicine 10 (8), 829-835, 2009 | 69 | 2009 |
| Eating decisions based on alertness levels after a single night of sleep manipulation: a randomized clinical trial D Pardi, M Buman, J Black, GJ Lammers, JM Zeitzer Sleep 40 (2), zsw039, 2017 | 25 | 2017 |
| Plasma total ghrelin and leptin levels in human narcolepsy and matched healthy controls: basal concentrations and response to sodium oxybate CEHM Donjacour, D Pardi, NA Aziz, M Frölich, F Roelfsema, S Overeem, ... Journal of Clinical Sleep Medicine 9 (8), 797-803, 2013 | 25 | 2013 |
| Back to the Future. Metabolic Effects of a 4-Day Outdoor Trip Under Simulated Paleolithic Conditions–New Insights from The Eifel Study J Freese Journal of Evolution and Health: A joint publication of the Ancestral Health …, 2013 | 17 | 2013 |
| Sodium oxybate: neurobiology and clinical efficacy D Pardi, JE Black Future Medicine Ltd 1 (6), 721-735, 2006 | 6 | 2006 |
| Molecular and cellular actions of g-hydroxybutyric acid: possible mechanisms underlying GHB efficacy in narcolepsy XS Xie, D Pardi, J Black Narcolepsy and hypersomnia, 621-658, 2006 | 4 | 2006 |
| Molecular and cellular actions of GHB: possible mechanims underlying GHB efficacy in narcolepsy X Xie, D Pardi, J Black Narcolepsy and Hypersomnia: Dekker, 2006 | 4 | 2006 |
| Nocturnal sodium oxybate for daytime sedation and fatigue in Parkinson’s disease, a polysomnogram trial WG Ondo, T Perkins, T Swick, K Hull, T Garris, E Jimenez, D Pardi Arch Neurology, 2008 | 2 | 2008 |
| Sodium oxybate for excessive daytime sleepiness in Parkinson's disease: A polysomnographic study W Ondo, A Perkins, T Swick, K Hull, E Jimenez, D Pardi Sleep 30, A287-A287, 2007 | 2 | 2007 |
| Exploring the relationships of gamma-hydroxybutyrate and sleep on metabolism, physiology, and behavior in humans DJ Pardi Leiden University, 2019 | | 2019 |
| NORMAL 24 HOUR GHRELIN LEVELS IN HUMAN NARCOLEPSY AND IN RESPONSE TO SODIUM OXYBATE C Donjacour, D Pardi, A Aziz, S Overeem, H Pijl, G Lammers SLEEP 33, A269-A269, 2010 | | 2010 |
| Exploring the relationships of gamma-hydroxybutyrate and sleep on metabolism DJ Pardi Drug and Alcohol Dependence 104 (1-2), 1-10, 2009 | | 2009 |
| Sodium oxybate-induced changes in nocturnal slow-wave sleep and delta power correlate with improvements in measures of daytime alertness and sleep continuity in patients with … J Black, P Perera, D Pardi, H Liang JOURNAL OF SLEEP RESEARCH 15, 196-196, 2006 | | 2006 |
| Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson’s Disease: A Polysomnographic Study MD William Ondo, MD Thomas Perkins, MD Todd Swick, LH Keith Jr, ... | | |
Roland R. GriffithsProfessor, Departments of Psychiatry and Neuroscience, Johns Hopkins University School of MedicineVerified email at jhmi.edu
